BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBP

All Eps Dividend Board Agm Q1 Q2 Q3

IBP 17-Nov-2019

(Q1 Un-audited): EPS was Tk. 0.43 for July-September, 2019 as against Tk. 0.34 for July-September, 2018. NOCFPS was Tk. 0.22 for July-September, 2019 as against Tk. 0.38 for July-September, 2018. NAV per share was Tk. 13.87 as on September 30, 2019 and Tk. 13.44 as on June 30, 2019.

IBP 11-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2019 at 5.00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

IBP 29-Oct-2019

There will be no price limit on the trading of the shares of the Company today (29.10.2019) following its corporate declaration.

IBP 29-Oct-2019

(Continuation news of IBP): ii) Bonus shares is declared out of accumulated profit. iii) Bonus shares is not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post-dividend retained earning become negative or a debit balance. (end)

IBP 29-Oct-2019

(Continuation news of IBP): Record Date: 21.11.2019. The Company has also reported EPS of Tk. 1.58, NAV per share of Tk. 13.44 and NOCFPS of Tk. 1.70 for the year ended on June 30, 2019 as against Tk. 1.35, Tk. 14.19 and Tk. 1.20 respectively for the same period of the previous year. The Company also informed that: i) Bonus Shares has been recommended in view to utilize its retained amount as capital for business expansion as well as working capital. (cont.2)

IBP 29-Oct-2019

The Board of Directors has recommended 2% cash for general shareholders & ICB (excluding Sponsors/Directors) and 9% stock dividend for all shareholders for the year ended on June 30, 2019. The Sponsors/Directors hold 3,59,35,900 shares out of total 10,23,00,000 shares of the Company and the cash dividend to be payable to the General shareholders of Tk. 13.273 million. Date of AGM: 12.12.2019, Time: 10:00 AM, Venue: Nishorgo Entertainment Zone, Nabogram, Barisal. (cont.1)

IBP 21-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2019 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

IBP 20-Oct-2019

The Company has informed that the Board of Directors of the Company has decided to purchase 145.43 decimal of land at 1st phase out of 1028 decimal Land for which bayna deed was made earlier. The land will be used for future expansion in Kaliakoir, Gazipur, to take advantages of economies of scale as well as better prospect for pharmaceutical business in future.

IBP 17-Sep-2019

The Company has informed that the Corporate office of the Company has been shifted to its new address at Plot # 183 (7th Floor), Block # B, Road # 4, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka-1229 with effect from September 16, 2019.

IBP 27-Aug-2019

The Company has informed that they have made a Manufacturing Agreement on August 26, 2019 with RHK GLOBAL (HK) LTD., Hong Kong, under which Super Tramex-100mg brand Tablet (Generic Name: Tramadol) will be produced in Indo-Bangla Pharmaceuticals Ltd.?s production plant, College road, Barisal, Bangladesh. As per the Agreement they will produce 1200 million Tablet/p.a. and the revenue of which is projected to be BDT 600 mn /p.a.

Previous Next page